debora jorn  viveve medical inc  zoominfocom deborah jorn  bausch  lomb incorporated  zoominfocom   insider trading  jorn debora  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  jorn debora select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na viveve medical inc vive jorn deboradirector   direct view option award  pm nana viveve medical inc vive jorn deboradirector   9direct view option award  pm na psivida corp psdv jorn deboraevp corp  comml dev  9 direct view option award  pm nana viveve medical inc vive jorn deboradirector   9direct view option award  pm na viveve medical inc vive jorn deboradirector 9  9direct view option award  pm na orexigen therapeutics inc orex jorn deboradirector   direct view option award  pm na9 orexigen therapeutics inc orex jorn deboradirector   direct view option award  pm na viveve medical inc vivmf jorn deboradirector   direct view tax withholding  pm nana valeant pharmaceuticals international inc vrx jorn deboraevp company group chairman   direct view   secformcom all rights reserved archives        sat 9 jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  stock screener  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow  listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballinsider transactionsdefault criteriainsider  restricted shareholder transactions of  resultsresults were generated a few mins ago pricing data is updated frequently currency in usdsymboldatesharesproceedstransaction detailsvivenaacquisition non open market at  per sharevivenaacquisition non open market at  per sharevivenaacquisition non open market at  per sharevrx9nadisposition non open market at  per shareanthony scaramuccis wife reportedly filed for divorce because he was hellbent on joining trumpbusiness insidersolar eclipse  stay in the tualatin valleythe tualatin valleysponsoredmainstream model  holds promise  and peril  for teslaassociated pressyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated deborah jorn profiles  facebook facebookemail or phonepasswordforgot accountenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   viveve medical inc viveo people  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states viveve medical inc viveo related topics stocksstock screenermarket datahealthcareadvanced medical equipment  technology overview news key developments people charts financials analysts research pulse viveo on consolidated issue listed on nasdaq capital market usd  jul  change  chg   prev close  open  days high 9 days low  volume 9 avg vol  wk high  wk low  summary name age since current position james atkinson   chief business officer and president patricia scheller   chief executive officer director scott durbin   chief financial officer alan curtis  vice president  regulatory clinical and quality steve lopez  director  operations lori bush 9  director debora jorn 9  director arlene morris   director jon plexico   director daniel janney   independent director » insider trading biographies name description james atkinson mr james g atkinson is chief business officer and president of viveve medical inc prior to joining viveve as chief business officer and president jim was the senior vice president of global sales at ulthera inc through april  he was the third employee to join the company in october  as senior vice president of sales and marketing while at ulthera he helped grow the company from  to  employees and established a global distribution network that included  distributors covering  countries ulthera was purchased by merz aesthetics for  million in  before joining ulthera mr atkinson served as vice president of sales and marketing for the cardiac surgery division at st jude medical where his responsibilities included launching the biocor stented tissue valve recognized as the fastest growing heart valve brand in the industry prior to st jude medical he served as vice president of sales for medtronic vascular a  million division of medtronic inc mr atkinsons entrepreneurial spirit led him to cofound and serve as vice president of sales and business development for medical simulation corporation the leading developer of stateoftheart simulation technologies and services for the cardiology cardiac surgery and nursing industries his career began as a sales representative at ethicon endosurgery where he progressed through positions of increasing responsibility to regional v patricia scheller ms patricia k scheller is chief executive officer director of viveve medical inc ms scheller was elected as a director of viveve medical inc on september   with her service beginning following the merger and has been a director of our whollyowned subsidiary viveve inc since june  ms scheller also serves as our chief executive officer and since may  as chief executive officer of viveve inc prior to joining viveve inc she served as the chief executive officer of prescient medical inc “pmi” a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks from september  through april  and as a director of pmi from july  to september  prior to joining pmi from august  to september  she was the chief executive officer of somalogic a biotechnology company focused on the development of diagnostic products using aptamer technology from december  to april  ms scheller also managed several business units at orthoclinical diagnostics a johnson  johnson company and from october 99 to november  served in key executive positions at dade behring a clinical diagnostics firm while at dade behring holdings inc she directed the commercialization of the hscrp diagnostic test a screening test for systemic inflammation which has been shown to increase the risk of heart attacks the hscrp test was the first diagnostic test added to the cardiac test panel by the centers for disease control and prevention and the american heart association in over  years scott durbin mr scott c durbin is chief financial officer of viveve medical inc mr durbin joined viveve inc as its chief financial officer in february  and was appointed as the chief financial officer of viveve medical inc on september   from june  to january  he served as an advisor and acting chief financial officer for viveve inc prior to joining viveve inc from june  to october  he was chief financial officer of aastrom biosciences “aastrom” a publicly traded cardiovascular cell therapy company before aastrom he spent six years as chief operating and financial officer for prescient medical “prescient” from may  to june  a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks prior to prescient from january  to april  he spent several years as a financial consultant for two publicly traded biotech companies scios inc – a johnson  johnson company and alteon inc mr durbin began his career in corporate finance as an investment banker in the healthcare and ma groups at lehman brothers inc from august 999 to january  where he focused on mergers and acquisitions and financings for the life science industry at lehman he successfully executed over  billion in transactions for medical device and biotechnology companies he began his career as a director of neurophysiology for biotronic inc mr durbin received a bs from the university of michigan and an mph in health management with honors from the yale university school of medicine and school of management alan curtis mr alan curtis is vice president  regulatory clinical and quality of viveve medical inc he joined viveve in january  in his role as vice president of regulatory clinical and quality alan brings over  years of experience to the organization alan has been involved in many medical device startups including aragon surgical reliant technologies surx and endosonics alan also gained pma approval for an interventional cardiology device while with wl gore and associates he has created and implemented robust quality systems to meet domestic and international regulatory requirements in addition alan has established successful clinical and regulatory strategies that led to device commercialization in the us as well as ce mark for international distribution alan is a member of the regulatory affairs professionals society and is certified as an rac alan attended california state university and received a bsc in microbiology steve lopez mr steve lopez is director of operations of viveve medical inc steve joined viveve in april 9 he brings over  years of engineering manufacturing quality and operational experience supporting asthma cardiovascular esophageal oncology and surgical products both in early stage and fortune  companies more recently steve worked at asthmatx now boston scientific as the director of operations where he led the transition from rd assembly into clinical manufacturing along with managing scaleup activities for commercial release steve has held various leadership and technical roles at bârrx medical now covidien boston scientific radiotherapeutics now boston scientific johnson  johnson and guidant now abbott vascular steve earned his ms degree in engineering management from california state university northridge received his bs degree in engineering from california state polytechnic university pomona and is a certified manufacturing engineer lori bush ms lori h bush is director of the company she has over  years of experience in the consumer and healthcare products industries with a proven track record in building highly successful brands most recently she served as president and chief executive officer of rodan  fields a premium skincare company that grew from a startup to over m in revenue during her  year tenure with the company ms bushs previous executive roles include president of nu skin and leadership positions in consumer products within johnson  johnson debora jorn ms debora jorn is director of the company she has extensive experience in building multibillion dollar us and global life science businesses she has a proven record of designing and implementing innovative business and marketing strategies that have delivered double digit organic growth across numerous therapeutic areas most recently ms jorn served as executive vice president and company group chair at valeant chief global marketing officer at bausch  lomb and group vice president for womens health and fertility at schering plough arlene morris ms arlene m morris is director of the company she joins the board with significant life science experience in the development of strategic partnerships and transactions global marketing product pipeline development and operations she has served as president and chief executive officer of syndax pharmaceuticals and has held executive leadership positions at johnson  johnsons orthomcneil pharmaceutical scios coulter pharmaceuticals clearview projects and affymax jon plexico mr jon m plexico is director of the company mr plexico is currently a managing member of stonepine capital management llc previously mr plexico was managing director at merriman curhan ford  co where he ran the healthcare corporate finance division focusing on private investments in public equity pipes secondary offerings and mergers and acquisitions prior to that mr plexico was cofounding partner of venture ready partners a life science advisor providing capital raising services to private biotechnology companies mr plexico served as director of business development at chemdex corporation an electronic lifescience commerce company that completed an initial public offering during his tenure he began his career at quidel corporation where he became national sales manager for the autoimmune division mr plexico is a graduate of colgate university daniel janney mr daniel s janney is independent director of viveve medical inc mr janney was elected as a director of viveve medical inc on september   with his service beginning following the merger since november  mr janney has served as a director of esperion therapeutics inc nasdaq espr mr janney is a managing director at alta partners a life sciences venture capital firm which he joined in 99 prior to joining alta from 99 to 99 he was a vice president in montgomery securities healthcare and biotechnology investment banking group focusing on life sciences companies mr janney is a director of a number of companies including alba therapeutics corporation lithera inc prolacta bioscience inc sutro biopharma and virobay inc he holds a bachelor of arts in history from georgetown university and an mba from the anderson school at the university of california los angeles because of mr janneys experience working with and serving on the boards of directors of life sciences companies and his experience working in the venture capital industry we concluded that he should serve as a director basic compensation name fiscal year total james atkinson  patricia scheller  scott durbin  alan curtis  steve lopez  lori bush  debora jorn  arlene morris  jon plexico  daniel janney  as of   dec  options compensation name options value james atkinson   patricia scheller   scott durbin   alan curtis   steve lopez   lori bush   debora jorn   arlene morris   jon plexico   daniel janney   insider trading name shares traded price jorn debora a   janney daniel spencer   plexico jon m 9  stonepine capital lp   atkinson james g   janney daniel spencer   atkinson james g   scheller patricia   jorn debora a   bush lori h   morris arlene m   janney daniel spencer   plexico jon m   jorn debora a   bush lori h   plexico jon m   morris arlene m   smith brigitte 9  janney daniel spencer 9  atkinson james g   scheller patricia   stonepine capital lp   durbin scott c   janney daniel spencer   scheller patricia   » full list on insider trading related topics stocksstock screenermarket datahealthcareadvanced medical equipment  technology debora jorn  valeant pharma insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsdebora jornvaleant pharma vrxevp company group chairman not rankeddebora jorns performancedebora jorn has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  valeant pharma vrxksee the top stocks by insiders  insider rolesvaleant pharma vrx evp company group chairmansee the top  corporate insiders  debora jorns trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datevrxvaleant pharmaevp company group chairmanuninformative sellnov  orexorexigendirectorpsdvpsividaevp corp  comml devsee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by